Antigua and Barbuda Vaccine Industry Outlook 2024 - 2028

See how Antigua and Barbuda Vaccine performed compared to key markets.

Key Market Indicators

Antigua's vaccination coverage for children aged one is projected to maintain a steady rate of 94 percent by 2028, unchanged from its current level in 2023. This stability in vaccination rates has been consistent since 2005. The long-term trend, dating back to 1985, shows that the vaccination coverage rate for one-year-olds in Antigua has remained stable without significant fluctuations. In terms of vaccine imports, Antigua is expected to see an increase. By 2028, the value of vaccine imports is forecasted to reach approximately $84,000, up from around $77,000 in 2023. This represents an average annual growth rate of 1.3 percent. However, since 2005, there has been a slight annual decrease of 0.5 percent in vaccine demand. On the export front, Antigua's vaccine exports are anticipated to rise. By 2028, exports are projected to be nearly $30,000, compared to about $25,000 in 2023, marking a compound annual growth rate of 2.8 percent. Since 2005, the country's vaccine supply has shown a robust average annual increase of 5.1 percent.

Antigua and Barbuda Vaccine Market Data and Forecasts

How much will Antigua and Barbuda Vaccine Market grow to 2028?

Forecast: Import of Vaccines for Human Use to Antigua and Barbuda
Forecast: Export of Vaccines for Human Use from Antigua and Barbuda
Forecast: Import of Vaccines for Human Use to Antigua and Barbuda

Other Top Countries about Vaccine